CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Debt and Lease Obligation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Debt and Lease Obligation of $1.65 billion as of 2018-12-29, per its 10-K filed 2019-02-13.
Discontinued › Balance Sheet › Liabilities › Debt
us-gaap:DebtAndCapitalLeaseObligations · last filed 2019-02-13
- 2018-12-29: Debt and Lease Obligation $1.65B.
- 2017-12-30: Debt and Lease Obligation $1.12B.
- 2016-12-31: Debt and Lease Obligation $1.21B.
- 2011-09-24: Debt and Lease Obligation $740.32M.
| Period end | Debt and Lease Obligation |
|---|---|
| 2018-12-29 | $1.65B 10-K · filed 2019-02-13 |
| 2017-12-30 | $1.12B 10-K · filed 2019-02-13 |
| 2016-12-31 | $1.21B 10-K · filed 2018-02-13 |
| 2011-09-24 | $740.32M 10-Q · filed 2011-11-02 |
| 2011-06-25 | $789.41M 10-Q · filed 2011-08-03 |
| 2010-12-25 | $700.85M 10-Q · filed 2011-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |